Evidence map›Paper›PMID 38511933›Full record

ArticlemBio2024

LVS Δ

Michael V Tullius, Richard A Bowen, Peter S Back, Saša Masleša-Galić, Susana Nava, Marcus A Horwitz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mBio, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Review
  2. rLVS ΔHuman vaccines & immunotherapeutics · 2025
    Article
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Michael V TulliusDivision of Infectious Diseases, Department of Medicine, Center for Health Sciences, School of Medicine, University of California, Los Angeles, California, USA.
Richard A BowenDepartment of Biomedical Sciences, Colorado State University, Fort Collins, Colorado, USA.
Peter S BackDivision of Infectious Diseases, Department of Medicine, Center for Health Sciences, School of Medicine, University of California, Los Angeles, California, USA.
Saša Masleša-GalićDivision of Infectious Diseases, Department of Medicine, Center for Health Sciences, School of Medicine, University of California, Los Angeles, California, USA.
Susana NavaDivision of Infectious Diseases, Department of Medicine, Center for Health Sciences, School of Medicine, University of California, Los Angeles, California, USA.
Marcus A HorwitzDivision of Infectious Diseases, Department of Medicine, Center for Health Sciences, School of Medicine, University of California, Los Angeles, California, USA.ORCID 0000-0001-6525-7147
University of California, Los Angeles · USColorado State University · US

Funding

Women's CancersP30CA016042 · NCI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Samuel Wheeler French · 1985 to 2026
$134.5M
Virology CoreP30AI028697 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ANTON, PETER A · 1991 to 2018
$39.9M
Development of a Safe and Potent Vaccine Against Melioidosis using the LVS dcapB Vector PlatformR01AI141390 · NIAID · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI HORWITZ, MARCUS AARON · 2019 to 2023
$3.9M
NCI NIH HHS P30 CA016042NIAID NIH HHS P30 AI028697NIAID NIH HHS R01 AI141390
6 · The paper itself

Abstract

Melioidosis, caused by the intracellular bacterial pathogen and Tier 1 select agent IMPORTANCE: Melioidosis, a major neglected disease caused by the intracellular bacterial pathogen

Indexed as

AnthraxBurkholderia pseudomalleiMelioidosisPlagueTularemiaAnimalsAntigens, BacterialBacterial VaccinesHumansMiceMice, Inbred BALB CVaccines, AttenuatedAntigens, BacterialBacterial VaccinesVaccines, AttenuatedBurkholderia pseudomalleilive attenuated vaccineLVS ΔcapBmelioidosisselect agentvaccine

Identifiers

PMID38511933
PMCPMC11005352
OpenAlexW4393040392

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.